| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 05/26/2004 | CN1498614A Camphor spraying agent as well as its producing method and product |
| 05/26/2004 | CN1151167C Purine derivatives |
| 05/26/2004 | CN1151133C Anthranilic acid amides and use thereof as medicaments |
| 05/26/2004 | CN1151131C Piperidine derivatives useful as CCR5 antagonists |
| 05/26/2004 | CN1150908C Prodn. method of seahorse powder capsule |
| 05/26/2004 | CN1150907C Usage of turtle oil, and trionxy oil |
| 05/26/2004 | CN1150898C Utilization of alkyl hydrogen fumerates for treating psoriasis, psoriatic arthrits, neurodermatitis and regional enterits |
| 05/25/2004 | US6740681 Inhibiting angiogenesis and/or inflammation |
| 05/25/2004 | US6740676 Treating diseases controlled by or responsive to retinoic acid |
| 05/25/2004 | US6740666 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 05/25/2004 | US6740655 3',5'-cyclic nucleotide phosphodiesterase 4-specific inhibitors reduce eosinophil influx to the lungs; side effect reduction; antiinflammatory agent; antiallergens; respiratory system disorders, especially asthma |
| 05/25/2004 | US6740647 Amidines and hydroxyamidine derivatives |
| 05/25/2004 | US6740327 Use for cosmetic and dermatological indications, reducing and soothing mucosa and skin erythema, inflammation or reaction caused by internal or external factors, wound healing, etc. |
| 05/21/2004 | WO2004042056A1 Physiologically active polypeptide and its antibody and use thereof |
| 05/21/2004 | WO2004041859A2 Peptide fragments of the harp factor inhibiting angiogenesis |
| 05/21/2004 | WO2004041812A1 Therapeutic compounds and methods |
| 05/21/2004 | WO2004041758A1 New stilbene derivatives and their use as aryl hydrocarbon receptor ligand antagonistics |
| 05/21/2004 | WO2004041266A1 Receptor function controlling agent |
| 05/21/2004 | WO2004041261A1 A kind of camphor spray and its preparation and a product containing it |
| 05/21/2004 | WO2004041236A1 Composition for preparation for external use on skin and method of using the same |
| 05/21/2004 | WO2004041235A1 Novel dermatological and/or cosmetologic hydrating and anti-irritation compositions |
| 05/21/2004 | WO2004030605A3 Cosmetic formulations based on a gel-forming and/or thickening agent and applications of same |
| 05/21/2004 | WO2004024106A3 Use of a cosmetic care product containing urea and cosmetic care product containing urea |
| 05/21/2004 | WO2004000817A3 Benzimidazole compounds and their use as estrogen agonists/antagonists |
| 05/21/2004 | WO2003103569A3 Toluidine blue o drug substance and use thereof for in vivo staining and chemotherapeutic treatment of dysplastic tissues |
| 05/21/2004 | WO2003088900A3 Solid forms of salts with tyrosine kinase activity |
| 05/21/2004 | WO2003084935A3 Diaryl pyrimidinone derivatives useful for the treatment of inflammation and immunogolical diseases |
| 05/21/2004 | WO2003080105A3 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof |
| 05/21/2004 | WO2003055440A8 Compositions and methods for the treatement of immune related diseases |
| 05/21/2004 | WO2003032933A8 Cosmetic and/or pharmaceutical superfatting preparations |
| 05/21/2004 | WO2003015724A8 Substances capable of potentiating laminin 5 productivity in epidermal cells and utilization thereof |
| 05/21/2004 | WO2003006001B1 ss-ADRENERGIC BLOCKADE REVERSAL OF CATABOLISM AFTER SEVERE BURN |
| 05/21/2004 | WO2003002125B1 Combination of aminosugars and cysteine or cysteine derivatives |
| 05/21/2004 | WO2002090361A8 Metal substituted non centrosimmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic |
| 05/21/2004 | WO2000058340A3 50 human secreted proteins |
| 05/21/2004 | CA2505322A1 Receptor function regulator |
| 05/21/2004 | CA2504999A1 Therapeutic compounds and methods |
| 05/21/2004 | CA2504270A1 Peptide fragments of the harp factor inhibiting angiogenesis |
| 05/20/2004 | US20040097867 Systems and methods for treating patients with processed lipoaspirate cells |
| 05/20/2004 | US20040097733 Bicyclic aromatic or heteroaromatic-amine compounds; Regulators of cell proliferation and differentiation; useful for treating skin related diseases; retinoid antagonist or retinoid inverse agonist-like biological activity |
| 05/20/2004 | US20040097714 Using microfiltration and/or diafiltration to isolate transforming growth factor from dairy products for use in treatment and prevention of cell proliferative, autoimmune, bone and inflammatory disorders; antitumor agents |
| 05/20/2004 | US20040097589 Thyroid receptor ligands, pharmaceutical compositions comprising them and their use in the treatment of disorders influenced by thyroid hormones |
| 05/20/2004 | US20040097585 4-(2,6-difluorophenyl)-4-oxobutyric acid and derivatives; milder side effects; insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis, arteriosclerosis |
| 05/20/2004 | US20040097563 4-6-Diphenyl pyridine derivatives as antiinflammatory agents |
| 05/20/2004 | US20040097548 For prophylaxis and therapy of from inflammation, allergic disease, pain, migraine headache, neuralgia, itching, cough, central nervous system disease, digestive organs disease, nausea, emesis, urination disorder, circulatory disease |
| 05/20/2004 | US20040097543 Use of cyclic 2,4-diphosphoclycerates (cdgp) and/or derivatives thereof in cosmetic and dermatological formulations |
| 05/20/2004 | US20040097537 6-phenylbenzonaphthyridines |
| 05/20/2004 | US20040097521 Clinical treatment |
| 05/20/2004 | US20040097506 Pyrimidine derivatives for inhibition of cell proliferation |
| 05/20/2004 | US20040097501 Triazole compounds useful as protein kinase inhibitors |
| 05/20/2004 | US20040097497 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors |
| 05/20/2004 | US20040097494 For use as nitric oxide synthase inhibitors |
| 05/20/2004 | US20040097487 To inhibits matrix metalloprotease activity |
| 05/20/2004 | US20040097472 Complexes of phosphate derivatives |
| 05/20/2004 | US20040097465 ll-12 expression controlling agents |
| 05/20/2004 | US20040097456 Using a cytokine for prophylaxis, therapy and diagnosis of skin related growth disorders in mammals |
| 05/20/2004 | US20040097455 Cloning of reporter genes and cDNA encoding for therapeutic proteins for the treatment of hepatic, pulmonary, renal, heart, pancreas fibrosis, keloids and hypertrophic scars, in mammals, including human beings |
| 05/20/2004 | US20040097434 For therapy of inflammatory diseases and conditions in humans and animals |
| 05/20/2004 | US20040097425 Peptide compounds |
| 05/20/2004 | US20040096925 Identifying enzyme inhibitors for treatment of skin, allergic and inflammatory disorders; cosmetics |
| 05/20/2004 | US20040096901 Chineric monocllonal antibody for treatment and prevention transplant rejection, psoriasis, inflammatory bowel, autoimmune and allergic disorders |
| 05/20/2004 | US20040096888 Comprises nucleotide sequences coding cyclin dependent kinase (PELOTA) for diagnosis, treatment, prognosis and prevention of cell proliferative, cardoivascular, inflammatory, arthritic disorders |
| 05/20/2004 | US20040096877 For diagnosis/treatment/prevention of inflammation/asthma/ allergies |
| 05/20/2004 | US20040096816 Method of indentifying an eventual modification of at least one biological parameter implementing young and aged living cells |
| 05/20/2004 | US20040096815 Comprises compared proteomic and/or compared transcriptomic and/or compared genomic analysis; enzyme-linked immunosorbent assay (ELISA) |
| 05/20/2004 | US20040096566 Method for obtaining cocoa bean polyphenol extracts, resulting extracts and uses thereof |
| 05/20/2004 | US20040096520 Manganese compositions for reducing/preventing skin wrinkles and fine lines |
| 05/20/2004 | US20040096513 Systemically minimizing the inflammatory effects of TNF- alpha are disclosed. The compositions include particles of bioactive glass with a particle size less than about 20 mu m, alone or in combination with anti-inflammatory agents and |
| 05/20/2004 | US20040096493 Preparing a therapeutic formulation containing phosphate derivatives of electron transfer agents comprising steps of phosphorylation and P4O10 to form a mixture of at least one mono-electron transfer agent phosphate derivative and at least |
| 05/20/2004 | US20040096487 Treating healed wounds including hypertrophic scars so as to prevent scarring or reduce the size and improve the appearance of scars comprises applying to the healed wound or scar a composition comprising a fluid, film-forming carriers |
| 05/20/2004 | US20040096447 Preventives/remedies for thickened scar, keloid or chronic arthritic diseases |
| 05/20/2004 | US20040096435 Methods for screening compounds that modulate lipid metabolism |
| 05/20/2004 | US20040096431 Providing a tissue removal system; removing adipose tissue from a patient using the tissue removal system, the adipose tissue having a concentration of stem cells; processing at least a part of the adipose tissue to obtain a concentration |
| 05/19/2004 | EP1420022A1 Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity |
| 05/19/2004 | EP1420019A1 Substituted pyridino pentaazamacrocyle ligands having superoxide dismutase activity |
| 05/19/2004 | EP1419764A1 Use of an association of synergic calcium channel blocker agents for preventing or treating wrinkles and fine lines |
| 05/19/2004 | EP1419264A2 Kinases and phosphatases |
| 05/19/2004 | EP1419256A2 Conjugates for the modulation of immune responses |
| 05/19/2004 | EP1419159A1 1-alkyl 0r 1-cycloalkyltriazolo 4,3-a]quinazolin-5-ones as phosphodiesterase inhibitors |
| 05/19/2004 | EP1419158A1 Pteridinone derivatives as modulators of chemokine receptor activity |
| 05/19/2004 | EP1419157A2 HETEROCYCLIC COMPOUND BASED ON N sp 6 /sp −SUBSTITUTED ADENINE, METHODS OF THEIR PREPARATION, THEIR USE FOR PREPARATION OF DRUGS, COSMETIC PREPARATIONS AND GROWTH REGULATORS, PHARMACEUTICAL PREPARATIONS, COSMETIC PREPARATIONS AND GROWTH REGULATORS CONTAINING THESE |
| 05/19/2004 | EP1419153A1 Rapamycin dialdehydes |
| 05/19/2004 | EP1419151A1 Chrystals including a malic acid salt of n-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3h-indole-3-ylidene)methyl]-2,4-dimethyl-1h-pyrrole-3-carboxamide, processes for its preparation and compositions thereof |
| 05/19/2004 | EP1419150A2 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use |
| 05/19/2004 | EP1419143A1 24-sulfur-substituted analogs of 1alpha,25-dihydroxy vitamin d3 |
| 05/19/2004 | EP1419119A1 Water-insoluble, antimicrobial silicate glass and use thereof |
| 05/19/2004 | EP1419118A1 Antimicrobial, anti-inflammatory, wound-healing glass powder and use thereof |
| 05/19/2004 | EP1418931A1 New drug |
| 05/19/2004 | EP1418911A1 2,4,5-trisubstituted thiazolyl derivatives ant their antiinflammatory activity |
| 05/19/2004 | EP1418904A2 Tocopherol enriched compositions and amelioration of inflammatory symptoms |
| 05/19/2004 | EP1418889A2 Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
| 05/19/2004 | EP1418881A2 Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide |
| 05/19/2004 | EP1339377A4 Use of cyclosporin 7-thioamide derivatives for hair growth |
| 05/19/2004 | EP1296695B1 Use of a polysaccharide excreted by the vibrio diabolicus species in bone repair |
| 05/19/2004 | EP1235824B1 Vitamin d analogues |
| 05/19/2004 | EP1220855B1 Anhydrous salt |
| 05/19/2004 | EP1190716B1 The leaves of cajanus cajan(l.) millsp and extract, formulation and uses thereof |
| 05/19/2004 | EP1034164B1 Substituted beta-alanine derivatives as cell adhesion inhibitors |
| 05/19/2004 | EP1011734B1 Gene therapy vehicle comprising dermal sheath tissue |
| 05/19/2004 | EP1009738B1 Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors |